CompletedNot Applicable

A Biologic Joint Replacement Strategy for Knee Trauma and Post-Traumatic Osteoarthritis

United States14 participantsStarted 2018-12-01

Plain-language summary

Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone marrow aspirate concentrate (BMC)-treated donor bone, and treatment-specific postoperative rehabilitation.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Grade IV changes in the articular cartilage of the femoral condyle and tibial plateau and meniscal pathology in the medial or lateral femorotibial joint (unicompartmental) or unicompartmental and other femoral condyle, tibial plateau, trochlea and/or patella. * Between the age of 18-55 Exclusion Criteria: * Acute injury to any other part of the affected lower extremity * Inability to comply with protocol * BMI greater than 40 * The subject is either pregnant or a prisoner * Currently involved in worker's compensation case at the time of enrollment

What they're measuring

VAS Pain Score (Visual Analog Scale)

Timeframe: 12 Months

Trial details

NCT IDNCT03719417

SponsorUniversity of Missouri-Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-01

View on ClinicalTrials.gov More Knee Osteoarthritis trials